?

Chadha Deepak

Former Chief R&D Officer & COO
Fresh Tracks Therapeutics, Inc.
US, Boulder [HQ]
CIK 1784380

Data Source

We automatically created this profile. The information was aggregated based on earnings call transcripts, insider forms and DEF 14A statements.

Latest Information

Shares :
37,292
Price per Share :
$0.66
Equivalence :
$24,612.72

Transaction History

  • M
    Form 4
    37,292 Shares After Transaction
    Value : $n/a
    $0.0
    09/01/23
  • Footnotes:
    #1 The restricted stock units were granted on January 24, 2023 and were subject to accelerated vesting as of the date of the reporting person's termination pursuant to his employment agreement with the issuer.
    #2 Each restricted stock unit converted into common stock on a one-for-one basis.
    #3 On July 5, 2022, the registrant effected a 1-for-45 reverse stock split ("Reverse Stock Split") of its common stock. The number of shares beneficially owned has been adjusted to give effect to the Reverse Stock Split.
    #4 This balance includes 555 shares purchased under the Fresh Tracks Therapeutics, Inc. Employee Stock Purchase Plan that were not previously reported.
    #5 Represents shares withheld by the issuer to satisfy tax withholding obligations upon the vesting of restricted stock units.
  • F
    Form 4
    22,314 Shares After Transaction
    Value : $13,834.68
    $9,286.36
    09/01/23